Optimal concentration range of ustekinumab in patients with plaque-type psoriasis

J Am Acad Dermatol. 2019 Jun;80(6):1782-1784. doi: 10.1016/j.jaad.2018.12.021. Epub 2018 Dec 19.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Cross-Sectional Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Maximum Tolerated Dose
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Severity of Illness Index
  • Statistics, Nonparametric
  • Treatment Outcome
  • Ustekinumab / blood*
  • Ustekinumab / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Ustekinumab